Bioinformatics analysis demonstrated that PCa tissues expressed lower levels of FRMD6 in comparison to normal prostate tissues and metastatic PCa tissues expressed even less FRMD6 compared to primary PCa samples. The gene discussed is FRMD6; the disease is posterior cortical atrophy.